A STUDENT nurse is one step closer to her dream of having a baby after shedding 115lbs on Mounjaro. Laurie Murray, from Airdrie, started using the weight loss jabs last April when she tipped the scales at 18st 10lbs. tiktok/@lauriewendymBefore weight loss jabs she was turned away for fertility help on the NHS[/caption] tiktok/@lauriewendymLaurie Murray … Read more

Hi r/supplements — I want to share some emerging research around fructose metabolism and a natural compound called Luteolin that I believe could be foundational to how we understand metabolic disease. First, full disclosure: I’m the founder of a company developing supplements targeting this pathway. I won’t name the company or link to any products … Read more

Eli Lilly completed a phase 3 trial for its weight loss drug, orforglipron, which showed promising results in evaluating its safety and efficacy for adults with Type 2 diabetes and inadequate glycemic control.  The once-daily oral GLP-1 receptor agonist significantly reduced blood sugar and body weight in adults with Type 2 diabetes and had a … Read more

Eli Lilly found its drug orforglipron led to significant weight and A1C reductions. Reuters Eli Lilly stock surged 12% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions. The pill form could expand access and reduce costs compared with injectable GLP-1 … Read more

Orforglipron, an oral GLP-1 receptor agonist developed by Eli Lilly, has shown positive Phase 3 results in treating type 2 diabetes and obesity. Unlike injectable GLP-1s like Ozempic, orforglipron offers a convenient, needle-free alternative with no food or water restrictions. Clinical trials demonstrated significant A1C reduction, and the drug’s safety profile is consistent with other … Read more

Drug manufacturers are racing to be the first to develop a GLP-1 pill for weight loss. Eli Lilly just announced promising new results for its product. Peter Meade/Getty Images Drugmaker Eli Lilly announced promising Phase 3 study results for its new GLP-1 pill. Orforglipron is a drug similar to Ozempic but without the injection, making … Read more

Orforglipron helps patients shed weight without injections–and puts Lilly years ahead of rivals in the GLP-1 raceRelated Stocks: NVO, AZN, VKTX,

This episode features audio from https://nutritionfacts.org/video/glp-1-weight-loss-drugs-like-ozempic-semaglutide-how-do-they-work-are-they-effective/ Visit the video page for all sources and doctor’s notes related to this podcast. https://NutritionFacts.org • Subscribe: https://nutritionfacts.org/subscribe • Donate: https://nutritionfacts.org/donate • Podcast : https://nutritionfacts.org/audio • Books: https://nutritionfacts.org/books • Shop: https://drgreger.org • Facebook: https://www.facebook.com/NutritionFacts.org • Twitter: https://twitter.com/nutrition_facts • Instagram: https://www.instagram.com/nutrition_facts_org